HAYA Therapeutics Partners with Lilly Gateway Labs to Enhance RNA-Guided Therapeutics Development
06/03/25, 5:22 PM
Location
Money
$65 million
Industry
manufacturing
Type
partnership
HAYA Therapeutics has relocated its U.S. operations to Lilly Gateway Labs in San Diego to leverage world-class facilities and a dynamic scientific environment. This move will support the advancement of their RNA-guided therapeutics platform and clinical development efforts for heart failure treatments.